Bob Nelsen — Co-founder, ARCH Venture Partners

**Robert "Bob" Nelsen** is the co-founder and Managing Director of **ARCH Venture Partners**, one of the world's most successful and prolific biotech venture capital firms with over $6 billion in assets under management. ARCH has been involved in the founding or early-stage financing of companies that have generated over $100 billion in aggregate market value, including **Illumina** (genomic sequencing), **Alnylam Pharmaceuticals** (RNAi therapeutics), **Juno Therapeutics** (cell therapy, acquired by Celgene for $9B), **Unity Biotechnology**, **Vir Biotechnology**, and dozens of others.